SG/CALL/ABBOTT LABORATORIES/130/0.1/21.03.25 Share Price

Warrant

DE000SW3PQ19

Market Closed - Deutsche Boerse AG 01:17:47 18/05/2024 am IST
0.16 EUR -5.88% Intraday chart for SG/CALL/ABBOTT LABORATORIES/130/0.1/21.03.25
Current month-34.62%
1 month-61.36%
Date Price Change
18/24/18 0.16 -5.88%
16/24/16 0.17 -5.56%
15/24/15 0.18 +5.88%
14/24/14 0.17 -10.53%
13/24/13 0.19 -5.00%

Delayed Quote Deutsche Boerse AG

Last update May 18, 2024 at 01:17 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW3PQ1
ISINDE000SW3PQ19
Date issued 19/09/2023
Strike 130 $
Maturity 21/03/2025 (308 Days)
Parity 10 : 1
Emission price 0.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.89
Lowest since issue 0.16
Spread 0.01
Spread %5.88%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.9 USD
Average target price
126.1 USD
Spread / Average Target
+20.28%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW